Lima M H, Campos M J, Valentim A, Paulo L, Rego S, Semedo E
Departamento de Anestesiología, Centro Hospitalario y Universitario de Coimbra, Coimbra, Portugal.
Departamento de Anestesiología, Centro Hospitalario y Universitario de Coimbra, Coimbra, Portugal.
Rev Esp Anestesiol Reanim (Engl Ed). 2019 Oct;66(8):447-450. doi: 10.1016/j.redar.2019.02.007. Epub 2019 Aug 5.
Trigeminal neuralgia (TN) is a severe and often underestimated facial pain that affects quality of life. Pharmacological treatment is insufficient for pain control in 30% of cases and, although intervention techniques may be effective, there is a possibility of relapse and associated complications. The second division of the trigeminal nerve (V2) runs through the sphenopalatine ganglion (SPG), which is anatomically accessible to blocking due to its superficial location in the nasal cavity. We report a clinical case of a patient with uncontrolled V2 TN that was put on ambulatory self-administered SPG block with nasal swabs soaked in 0.75% ropivacaine. In the follow-up visits, we confirmed that this adjuvant treatment provided a significant pain relief over 24hours with a decrease in the number of exacerbations.
三叉神经痛(TN)是一种严重且常被低估的面部疼痛,会影响生活质量。30%的病例中,药物治疗不足以控制疼痛,尽管干预技术可能有效,但仍有复发及相关并发症的可能性。三叉神经第二支(V2)穿过蝶腭神经节(SPG),因其在鼻腔中的浅表位置,在解剖学上可进行阻滞。我们报告了一例V2 TN控制不佳的患者的临床病例,该患者采用浸有0.75%罗哌卡因的鼻拭子进行门诊自我蝶腭神经节阻滞。在随访中,我们证实这种辅助治疗在24小时内提供了显著的疼痛缓解,且发作次数减少。